1-11 of 11
Jinny Park, MD PhD
Close
Sort by
Journal Articles

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

Sung-Eun Lee, MD, Joon Seong Park, MD, Hyeoung-Joon Kim, MD PhD, Sung-Hyun Kim, MD PhD, Dae Young Zang, MD PhD, Sukjoong Oh, MD PhD, Young Rok Do, PhDMD, Yunsuk Choi, MD, Jae-Yong Kwak, MD PhD, Jeong-A Kim, MD PhD, Kyoo Hyung Lee, MD PhD, Yeung-Chul Mun, MD, Won Sik Lee, MD PhD, Myung Hee Chang, MD, Jinny Park, MD PhD, Jihyun Kwon, MD, Dong-Wook Kim
Journal: Blood
Blood (2019) 134 (Supplement_1): 1643.
https://doi.org/10.1182/blood-2019-126376
Published: 2019
Journal Articles

Evaluation of Clinical Usefulness of Monocyte Gating Using CD14 and CD64 for Detecting PNH Clone By Flow Cytometry

Woo Jae Kwoun, MD, Jeong-Yeal Ahn, MD, Ja Young Seo, MD, Jae Hoon Lee, MD PhD, Hawk Kim, MD PhD, Jinny Park, MD PhD, Kwai Han Yoo, MD, Sung-Ran Cho, MD, Hye Ryoun Kim, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4947.
https://doi.org/10.1182/blood-2018-99-111468
Published: 2018
Journal Articles

Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up

Young Rok Do, PhDMD, Jae-Yong Kwak, MD PhD, Hawk Kim, MDPhD, Jeong-A Kim, MD PhD, Hyeoung-Joon Kim, MD PhD, Joon Seong Park, MD, Jooseop Chung, MD PhD, Ho-Jin Shin, MD PhD, Sung-Hyun Kim, MD PhD, Udomsak Bunworasate, MD, Chul Won Choi, MD PhD, Narcisa Sonia Cornejo Comia, MD, Dae Young Zang, MDPhD, Sukjoong Oh, MDPhD, Saengsuree Jootar, MD, Ary Harryanto Reksodiputro, MDPhD, Won-Sik Lee, MD, Yeung-Chul Mun, MD PhD, Jee Hyun Kong, MD, Priscilla B. Caguioa, MD, Jinny Park, MD PhD, Chul W. Jung, MD PhD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1733.
https://doi.org/10.1182/blood-2018-99-110568
Published: 2018
Journal Articles

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Jungmin Jo, Sung Hwa Bae, MD, Jinny Park, MD PhD, Hong-ghi Lee, MD PhD, Chul Won Choi, MD PhD, Yong Park, MD PhD, Ho Sup Lee, MD, Sung-Hyun Kim, MD PhD, Won-Sik Lee, MD, Soo-Mee Bang, MDPhD, Jun-Ho Jang, Inho Kim, MD PhD, Je-Hwan Lee, MD PhD, June-Won Cheong, MDPhD, Seong Kyu Park, MD, Jong-Ho Won, MD, Min Kyoung Kim, MD PhD, Hyeok Shim, MD, Yeung-Chul Mun, MD PhD, Jae-Sook Ahn, Deog-Yeon Jo, MD PhD, Dae Young Zang
Journal: Blood
Blood (2017) 130 (Supplement 1): 4257.
https://doi.org/10.1182/blood.V130.Suppl_1.4257.4257
Published: 2017
Journal Articles

Deeper Molecular Response in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 36 Months Follow-up

Young Rok Do, MD PhD, Hawk Kim, MD PhD, Jae-Yong Kwak, Jeong-A Kim, Hyeoung-Joon Kim, Joon Seong Park, MD, Jooseop Chung, MD PhD, Ho-Jin Shin, MD PhD, Sung-Hyun Kim, MD PhD, Udomsak Bunworasate, MD, Chul Won Choi, MD PhD, Narcisa Sonia Cornejo Comia, MD, Dae Young Zang, Sukjoong Oh, Saengsuree Jootar, MD, Ary Harryanto Reksodiputro, MDPhD, Won-Sik Lee, MD, Yeung-Chul Mun, MD PhD, Jee Hyun Kong, Priscilla B. Caguioa, MD, Jinny Park, MD PhD, Chul W. Jung, MD PhD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 317.
https://doi.org/10.1182/blood.V130.Suppl_1.317.317
Published: 2017
Journal Articles

PPARγ Agonists Inhibit Adhesion Signal to Endothelial Cells in the Differentiation Induction of HL-60 Acute Promyelocytic Leukemia Cells

Jinny Park, MD PhD, JiWon Yoon, Hong-Nu Yu, MD PhD, Eun-Mi Noh, PhD, On-Yoo Hong, Jong-Suk Kim, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5131.
https://doi.org/10.1182/blood.V128.22.5131.5131
Published: 2016
Journal Articles

Results from the Korean Imatinib Discontinuation Study (KIDS): Updated Data with 15-Month Median Follow up

Yunjeong OH, Soo Young Choi, Sung-Eun Lee, Soo-Hyun Kim, Hyeoung-Joon Kim, MD PhD, Yeo-Kyeoung Kim, MD PhD, Joon Seong Park, MD, Seong Hyun Jeong, MD, Sung-Hyun Kim, MD PhD, Dae Young Zang, MD, Sukjoong Oh, MD PhD, Dong Hoe Koo, MD, Hawk Kim, Young Rok Do, MD, Jae-Yong Kwak, MD PhD, Jeong-A Kim, MD PhD, Yeung-Chul Mun, Won Sik Lee, MD PhD, Myung Hee Jang, MD, Jinny Park, MD PhD, Ho-Jin Shin, MD, PhD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3155.
https://doi.org/10.1182/blood.V124.21.3155.3155
Published: 2014
Journal Articles

A Prospective Randomized Comparison of Cyclophosphamide Versus Fludarabine in Addition of Antithymocyte Globuline for Allogeneic Hematopoietic Cell Transplantation in Patients with Adult Severe Aplastic Anemia; Interim Analysis

Hawk Kim, MD, PhD., Won-Sik Lee, Yeo-Kyeoung Kim, MD PhD, Young-Don Joo, Jinny Park, MD PhD, Chul Won Jung, MD PhD, Jae-Cheol Jo, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD, Dae-Young Kim, MD, Kyoo-Hyung Lee, MD
Journal: Blood
Blood (2014) 124 (21): 3890.
https://doi.org/10.1182/blood.V124.21.3890.3890
Published: 2014
Journal Articles

Clinical Symptom Or Sign-Directed Surveillance Can Be More Useful In Detecting Relapse Compared To Routine Imaging In Patients With Diffuse Large B-Cell Lymphoma In Remission

Junshik Hong, MD, Ji Hyun Kim, MD, Jinny Park, MD, PhD, Jae Hoon Lee
Journal: Blood
Blood (2013) 122 (21): 2914.
https://doi.org/10.1182/blood.V122.21.2914.2914
Published: 2013
Journal Articles

Results From The Korean Imatinib Discontinuation Study (KIDS): Updated Data With 14-Month Median Follow Up

Yun jeong Oh, Soo Young Choi, Sung-Eun Lee, Soo-Hyun Kim, Hyeoung-Joon Kim, MD, PhD, Yeo-Kyeoung Kim, MD.PhD., Joon Seong Park, Seong Hyun Jeong, MD, Sung-Hyun Kim, MD, PhD, Dae Young Zang, Sukjoong Oh, Dong Hoe Koo, M.D, Hawk Kim, M.D., Young Rok Do, M.D., Jae-Yong Kwak, Jeong-A Kim, MD, PhD, Dae-Young Kim, Yeung-Chul Mun, Won Sik Lee, M.D., Myung Hee Chang, MD, Jinny Park, MD, PhD, Ho-Jin Shin, DongWook Kim
Journal: Blood
Blood (2013) 122 (21): 4003.
https://doi.org/10.1182/blood.V122.21.4003.4003
Published: 2013
Journal Articles

Tumor Necrosis Factor-α Enhances DMSO-Induced Differentiation of HL-60 Cells through Activation of ERK/MAPK Pathway.

Jinny Park, MD.,PhD, Young-Rae Lee, MS, Eun-Mi Noh, BS, Myung-Kwan Han, PmS,PhDp, Jung Ryul Ahn, MD.PhD, Young Sang Kim, MD, Se Hoon Park, MD, En Kyung Cho, MD.PhD, Dong Bok Shin, MD.PhD, Jae Hoon Lee, MD.PhD, Jong-Suk Kim, MD.PhD
Journal: Blood
Blood (2007) 110 (11): 4386.
https://doi.org/10.1182/blood.V110.11.4386.4386
Published: 2007